Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Little Green Pharma Ltd. ( (AU:LGP) ) has shared an announcement.
Little Green Pharma Ltd reported a significant financial turnaround for the year ending March 31, 2025, with revenues increasing by 42.8% to $36.8 million and a profit of $3.3 million, compared to a loss in the previous year. The company gained control over HHI (Australia) Pty Ltd and deregistered two entities, reflecting strategic adjustments in its operations.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd operates in the medicinal cannabis industry, focusing on the production and sale of cannabis oil, flower, and vaporiser products.
Average Trading Volume: 101,264
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$30.4M
For a thorough assessment of LGP stock, go to TipRanks’ Stock Analysis page.